Compare · CELL vs VGR
CELL vs VGR
Side-by-side comparison of PhenomeX Inc. (CELL) and Vector Group Ltd. (VGR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELL and VGR operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- VGR carries a market cap of $1.74B.
- VGR has more recent analyst coverage (4 ratings vs 0 for CELL).
- Company
- PhenomeX Inc.
- Vector Group Ltd.
- Price
- $1.00+0.14%
- $14.99+0.20%
- Market cap
- -
- $1.74B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 4
Vector Group Ltd.
Vector Group Ltd., through its subsidiaries, manufactures and sells cigarettes in the United States. It operates in two segments, Tobacco and Real Estate. The company produces cigarettes in 100 combinations under the EAGLE 20's, Pyramid, Montego, Grand Prix, Liggett Select, Eve, and USA brand names, as well as various partner and private label brands. In addition, it provides residential real estate brokerage, relocation, real estate sales and marketing, and title insurance services to real estate buyers and financial institutions; manages cooperative apartment buildings, condominium apartment buildings, and rental apartment buildings; and invests in, acquires, and owns real estate properties or projects, as well as develops land. Further, the company operates elliman.com, a website that enables consumers to search properties and access current market information, as well as offers building and neighborhood guides, and other interactive content. It markets and sells its cigarettes to wholesalers and distributors of tobacco and convenience products, as well as grocery, drug, and convenience store chains. The company was formerly known as Brooke Group Ltd. and changed its name to Vector Group Ltd. in May 2000. Vector Group Ltd. was founded in 1873 and is based in Miami, Florida.
Latest CELL
- PhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic Platform
- PhenomeX Announces The Release Of SpotLight Human Lambda Reagent For The Beacon Platform To Accelerate Cell Line Development Workflows
- PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows
- PhenomeX to Participate in Upcoming Cell Biology Conferences
- PhenomeX Unveils Meteor Chips For Quantitative Bulk Analysis On The IsoSpark Platform To Revolutionize High Throughput Multiplexed Hands-Free Proteomic
- PhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free Proteomics
- PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker
- Cathie Wood's Bullish Stance on Flying Cars: Ark Buys $3.9M Worth of Archer Aviation Shares
- Lifshitz Law PLLC Announces Investigations of TMBR, PR, ESTE, and CELL
- Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2023
Latest VGR
- SEC Form 15-12G filed by Vector Group Ltd.
- Amendment: SEC Form SC 13D/A filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.